Healthcare Global Enterprises Li (NSE: HCG, BSE: 539787) is a Bengaluru, Karnataka-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹8,782 Cr, it ranks #633 by market cap among the 6,137 Indian listed companies on FinBizNet, and #12 of 42 in Hospitals and Healthcare Centers. At ₹549.65 (as of 25 Oct 2026), the share price is 31.7% below its 52-week high of ₹804.65 and 7.1% above its 52-week low of ₹513.30. The share price is down 22.5% over one year and down 17.5% over three months.
| Current Price | ₹549.65 |
|---|---|
| Market Cap | ₹8,782 Cr |
| NSE Symbol | HCG |
| BSE Code | 539787 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 592.8 |
| Return on Equity | 1.90% |
| Return on Assets | 3.81% |
| 52-Week Range | ₹513.30 – ₹804.65 |
| 1-Year Price Change | -22.5% |
| 3-Month Price Change | -17.5% |
| Beta (1Y) | 0.34 |
| Headquarters | Bengaluru, Karnataka |
| Website | www.hcgoncology.com |
| Revenue | ₹695 Cr |
|---|---|
| Net Profit | ₹16 Cr |
| Net Margin | 2.2% |
| EPS (Basic) | ₹0.92 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services comprising patient care, psychological support, nutrition and dietetics, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology,
1. Setting up and Managing Hospitals and Medical Diagnostic Services-This segment owns and operates cancer centers, diagnostic centers, fertility clinics, clinical reference laboratories, and multi-specialty hospitals.
1. Setting up and Managing Hospitals and Medical Diagnostic Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,13,446 Cr | 57 | 21.50% | ₹7,044 Cr | -1.3% |
| Manipal Health Enterprises Ltd | ₹84,500 Cr | 82.1 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹82,242 Cr | 56.3 | 14.33% | ₹2,366 Cr | -30.7% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,702 Cr | 88.7 | 10.07% | ₹1,311 Cr | -7.8% |
| Fortis Healthcare Ltd. | ₹55,603 Cr | 53.3 | 11.01% | ₹2,545 Cr | -34.9% |
| Global Health Ltd (Medanta) | ₹33,340 Cr | 60 | 15.03% | ₹1,304 Cr | -15.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹27,434 Cr | 112.5 | 9.72% | ₹1,180 Cr | -9.4% |
| Dr. Agarwal's Health Care Limited | ₹14,767 Cr | 112 | 8.31% | ₹614 Cr | -9.3% |
| Healthcare Global Enterprises Li | ₹8,782 Cr | 592.8 | 1.90% | ₹695 Cr | -22.5% |
Listed by market capitalisation. Ratios are shown for context only.
Healthcare Global Enterprises Li is trading at ₹549.65, with a market capitalisation of ₹8,782 Cr.
Healthcare Global Enterprises Li operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Healthcare Global Enterprises Li has a P/E of 592.8 and a return on equity of 1.90%.
Healthcare Global Enterprises Li is listed on the NSE under the symbol HCG and on the BSE under the scrip code 539787.
Healthcare Global Enterprises Li's share price is down 22.5% over one year and down 17.5% over three months. Its 52-week range is ₹513.30 to ₹804.65.
In Q1 FY27, Healthcare Global Enterprises Li reported revenue of ₹695 Cr and net profit of ₹16 Cr, with basic EPS of ₹0.92 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.